Literature DB >> 16446129

High-performance liquid chromatography spectrometric analysis of trans-resveratrol in rat plasma.

Hui He1, Xijing Chen, Guangji Wang, Jiping Wang, Andrew Keith Davey.   

Abstract

A HPLC method for determination of trans-resveratrol concentrations in rat plasma was developed. Plasma samples were treated with acetonitrile to deposit proteins. The analysis used a Hypersil ODS(2) C(18) column (5 microm, 4.6 mm x 250 mm) and methanol/distilled water as the mobile phase (flow-rate=1 mL/min). The UV detection wavelength was 303 nm, and chlorzoxazone was used as the internal standard. The calibration curve was linear over the range of 0.02-40 microg/mL with a correlation coefficient of 0.9997. This concentration range corresponds well with the plasma concentrations of resveratrol in pharmacokinetic studies. There was 98.7%, 91.3% and 84.4% recovery from 0.02, 0.4 and 40 microg/mL plasma samples respectively. The R.S.D. of intra- and inter-day assay variations were all less than 12%. This HPLC assay is a quick, precise and reliable method for the analysis of resveratrol in pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446129     DOI: 10.1016/j.jchromb.2005.12.021

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFα.

Authors:  Nasui Wang; Seung-Hyun Ko; Weidong Chai; Guolian Li; Eugene J Barrett; Lijian Tao; Wenhong Cao; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

2.  Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.

Authors:  S N Shrotriya; N S Ranpise; B V Vidhate
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

3.  Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography.

Authors:  David J Boocock; Ketan R Patel; Guy E S Faust; Daniel P Normolle; Timothy H Marczylo; James A Crowell; Dean E Brenner; Tristan D Booth; Andreas Gescher; William P Steward
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-11-09       Impact factor: 3.205

4.  Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.

Authors:  Khalid A Ansari; Pradeep R Vavia; Francesco Trotta; Roberta Cavalli
Journal:  AAPS PharmSciTech       Date:  2011-01-15       Impact factor: 3.246

5.  Pre-formulation studies of resveratrol.

Authors:  Keila Robinson; Charlotta Mock; Dong Liang
Journal:  Drug Dev Ind Pharm       Date:  2015-07-21       Impact factor: 3.225

6.  Determination of quercetin and resveratrol in whole blood--implications for bioavailability studies.

Authors:  Lucia Biasutto; Ester Marotta; Spiridione Garbisa; Mario Zoratti; Cristina Paradisi
Journal:  Molecules       Date:  2010-09-20       Impact factor: 4.411

7.  Resveratrol-loaded polymeric nanoparticles: validation of an HPLC-PDA method to determine the drug entrapment and evaluation of its antioxidant activity.

Authors:  Gabriela da Rocha Lindner; Najeh Maissar Khalil; Rubiana Mara Mainardes
Journal:  ScientificWorldJournal       Date:  2013-10-24

8.  Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.

Authors:  Yang Han; Xiaoyang Chu; Lin Cui; Shiyao Fu; Chunsheng Gao; Yi Li; Baoshan Sun
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.